EPM2A antibody (AA 244-331)
Quick Overview for EPM2A antibody (AA 244-331) (ABIN6140229)
Target
See all EPM2A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 244-331
-
Sequence
- MLPQAVCLLH ALLEKGHIVY VHCNAGVGRS TAAVCGWLQY VMGWNLRKVQ YFLMAKRPAV YIDEEALARA QEDFFQKFGK VRSSVCSL
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 244-331 of human EPM2A (NP_005661.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
Alternative Name
- EPM2A
-
Background
- This gene encodes a dual-specificity phosphatase that associates with polyribosomes. The encoded protein may be involved in the regulation of glycogen metabolism. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. Alternative splicing results in multiple transcript variants.,EPM2A,EPM2,MELF,laforin,Signal Transduction,Endocrine & Metabolism,EPM2A
-
Molecular Weight
- 9 kDa/15 kDa/20 kDa/22 kDa/24 kDa/35 kDa/37 kDa
-
Gene ID
- 7957
-
UniProt
- O95278
-
Pathways
- Cellular Glucan Metabolic Process
Target
-